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Abstract 
   Meprins, metalloproteases that are highly expressed in the brush-border membranes of 
kidney proximal tubules, have been associated with ischemia-reperfusion induced kidney injury.  
Osteosarcoma 9 (OS9), a peripheral membrane protein, has been shown to selectively interact 
with the carboxyl-terminal tail of meprin beta (β).   Additionally, OS9 was shown to promote 
oxygen-dependent degradation of the hypoxia-inducible factor 1α (HIF1α), a protein involved in 
oxygen homeostasis.   However, it is not known if OS9 is a meprin substrate.  The objective of 
this study was to determine if OS9 is a meprin substrate, and whether there is a correlation 
between expression of meprins, OS9, and HIF1α under hypoxic conditions.    
To determine if meprins are capable of degrading OS9, purified human OS9 was co-
incubated with activated recombinant forms of meprin A and B.  Our results show that meprin B 
cleaves/degradation OS9. This was not observed for meprin A, suggesting isoform-specific 
cleavage.  Mardin-Darby canine kidney (MDCK) cells and human embryonic kidney 293 cells 
transfected with meprin α or β cDNA were depleted of oxygen by exposure to 125 µM cobalt 
chloride.  Non-transfected cells served as controls.  Western blot analysis was used to evaluate 
the nuclear fraction levels of OS9 and HIF1α. Our data showed that HIF-1α stabilized in the 
nucleus in a time-dependent manner and the levels of OS9 increased in non-transfected controls 
cells depleted of oxygen.  To our knowledge, this is the first study to identify OS9 as a meprin B 
substrate.  The degradation of OS9 by meprin B could impact the hypoxic response in kidney 
cells.   
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CHAPTER 1 
Introduction 
1.1 Life’s Requirement for Oxygen and Energy 
 Cells utilize oxygen for energy production in the form of adenosine-5´-triphosphate 
(ATP) to carry out cellular functions.  During oxidative phosphorylation, oxygen serves as an 
electron acceptor in the formation of ATP.  An adequate supply of oxygen is essential for cells to 
perform their functions and for cells to survive.  Cells must try to compensate under low levels of 
oxygen known as hypoxia.  If a cell is unable to compensate, or if there is an abrupt lack of 
oxygen, then it can lead to cell death.    In vitro models have been developed and to study the 
effects of hypoxia and ATP-depletion in cells.  These methods include using pharmacological 
agents to induce hypoxia and ATP-depletion in cultured.      
1.2 Ischemia-Reperfusion Injury 
 An organ may experience ischemia (restriction of blood supply) by an event such as 
physical blockage, organ transplantation, or diabetic chronic kidney failure.  The organ is starved 
of oxygen and nutrients until blood flow restoration occur.  The sudden rush of blood, containing 
oxygen and other nutrients, creates a catastrophic event within the organ resulting in tissue 
damage or disease.  The damage resulting from the return of blood after a period of ischemia is 
termed ischemia-reperfusion injury.  Ischemia results in oxygen- and ATP-depletion both of 
which have been shown to disrupt the cell cytoskeleton and its associated membrane structures 
(Ongeri, Anyanwu, Reeves, & Bond, 2011).  The damage caused to cells under hypoxia and the 
inability to produce ATP is of great significance.  Research is required to understand the 
pathogenesis of disease to organs that have experienced ischemia-reperfusion injury.  
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1.3 Meprins and Osteosarcoma 9 
 Meprins are metalloproteases that are highly expressed in the brush-border membranes of 
kidney proximal tubules.  Meprins are capable of degrading extracellular matrix proteins, and 
processing certain bioactive peptides.  Changes in the level of expression and localization of 
meprins have been associated with the pathology of ischemia-reperfusion induced kidney injury 
in mice and rats (Bylander et al., 2008; Carmago, Shah, & Walker, 2002; Trachtman, 
Valderrama, Dietrich, & Bond, 1995; Walker, Kaushal, & Shah, 1998).  Recent research has 
identified two cytoskeletal proteins, actin and villin, as meprin substrates (Ongeri et al., 2011).   
 Osteosarcoma 9 (OS9) is a protein associated with the cytoplasmic side of the 
endoplasmic reticulum.  OS9 plays a role in the endoplasmic reticulum (ER) associated 
degradation pathway, and binds to the key regulator of cellular hypoxic response known as 
hypoxia-inducible factor 1 (HIF1).  In 2002, the research of Litovchick et al. showed that OS9 
interacts specifically with the intracellular region of meprin B.  However, it is not known 
whether OS9 is a meprin substrate.  Beak et al. (2005) demonstrated that OS9 is a negative 
regulator of HIF-1α.  To date, no research has provided a correlation between the expression 
levels of OS9 and the master regulator of homeostasis gene of HIF1α.   
1.4 Objectives and Impact 
 The objective of the current research was to determine if OS9 is a meprin substrate and 
investigate the mechanism(s) by which meprins enhance damage to the kidney, using an in vitro 
kidney cell model.  The central hypothesis is that OS9 is a substrate of meprin.  A second 
objective was to evaluate how meprins impact the expression of OS9 and the hypoxia response 
gene HIF-1α.   
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           Meprins have been associated with damage and disease to the kidneys during ischemia 
reperfusion and diabetic chronic kidney failure.    The identification of meprin substrates and its 
role in the hypoxia response would be useful in the development of treatments for patients 
undergoing kidney transplants.  Stopping this process or reducing the rate of the enzyme would 
minimize organ damage which occurs in the process of ischemia-reperfusion injury.   
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CHAPTER 2 
Literature Review 
2.1 Ischemia-Reperfusion 
  Periods of time may exist when blood flow is cut off from an organ; thus, oxygen and 
nutrients can no longer be delivered to the organ.  The shortage of blood supply is termed 
ischemia, and hypoxia occurs during ischemia.  Reperfusion is when blood flow is restored after 
a period of deficient blood flow.  Situations which could lead to (ischemia-reperfusion (IR) 
include immobility, stroke, heart attack, organ transplantation, transfusion, physical blockage, 
and diabetic chronic kidney failure.  The lack of oxygen and nutrients from blood during the 
ischemic period creates a condition in which the restoration of circulation results in inflammation 
and oxidative damage through the induction of oxidative stress rather than restoration of normal 
function.  Ischemic injury is the leading cause of acute kidney disease (Gunaratnam & 
Bonventre, 2009).  Five percent of hospital patients are inflicted with ischemic acute tubular 
necrosis with a mortality rate of 50% (Ympa, Sakr, Reinhart, & Vincent, 2005).  Studies show 
that the pars recta (SC segment) of proximal tubules is the most susceptible to injury (Heyman, 
Shina, Brezis, & Rosen, 2002; Lieberthal & Nigam, 1998).  Chronic hypoxia leads to end stage 
renal disease.  The important effector of tubular cell injury during prolonged hypoxia is ATP-
depletion (Devarajan, 2006).   Reperfusion injury develops hours or days after the influx event 
(Kosieradzki & Rowinski, 2008).  The sudden rush of flow back into the organ causes a cascade 
of events.  A disruption in the cytoskeleton leads to loss of brush-border, a breakdown of cell 
junctions, and the incorrect relocalization of sodium-potassium ATPases from the basal surface 
to the apical surface (Gunaratnam & Bonventre, 2009).  Newly freed intracellular molecules of 
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calcium activate proteases and phospholipases.  This reperfusion event is the causative agent of 
oxidative injury to tubular cells (Bonventre & Zuk, 2004). 
            Ischemic diseases of the kidney lead to an imbalance of vasoactive substances and 
vasoconstrictors.  The accumulation of vasoconstrictors initiates pro-inflammatory and 
chemotactic cytokines that begins the up-regulation of adhesion molecules.  Leukocytes adhere 
within the site and release cytotoxic cytokines, reactive oxygen species, and proteolytic enzymes 
resulting in even more damage to the tubular cells (Bonventre & Zuk, 2004).  Cells will attempt 
to recover from the ischemia-induced damage by repairing/regenerating themselves via 
undergoing processes of apoptosis, autophagy, and/or necrosis (Kosieradzki & Rowinski, 2008).  
The extent of damage to the organ depends on whether more cells die or if more cells are able to 
regenerate.    
2.2 Meprins  
Meprins are zinc metalloproteases that are highly expressed in the brush-border 
membranes (BBM) of kidney proximal tubules.  Meprins belong to the astacin family (J. S. Bond 
& Beynon, 1995; Johnson & Bond, 1998).  Meprins are also found in the skin, pancreas, testis, 
regions of the brain, liver, heart, and leukocytes (Becker-Pauly et al., 2007; Crisman, Zhang, 
Norman, & Bond, 2004; Huguenin et al., 2008; Kenny & Ingram, 1987; Molitoris, Dahl, & 
Geerdes, 1992).  Meprins are capable of degrading extracellular matrix proteins such as collagen 
and fibronectin (Kaushal, Walker, & Shah, 1994; Walker et al., 1998), and processing bioactive 
proteins such as neurotension and gastrin (Chestukhin, Muradov, Litovchick, & Shaltiel, 1996; 
Sterchi, Naim, Lentze, Hauri, & Fransen, 1988).  Meprins are the only known endopeptidase in 
the BBM that degrades proteins:  others either only degrade small polypeptides, or are 
exopeptidases (J. S. Bond, and Jiang, W., 1997).  Five percent of the total protein found in BBM 
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is meprin with expression being localized to the apical membrane of proximal tubule S3 cells 
(Craig, Reckelhoff, & Bond, 1987).  Meprins were identified as the major matrix-degrading 
enzymes in rat renal tubules (Kaushal et al., 1994; Walker, Kaushal, & Shah, 1994). 
           The proteolytic enzymatic activity of meprins makes them essential components of 
cellular activities.  Due to their destructive potential, meprins must be highly regulated.  
Regulation is accomplished through zymogen formation, inhibition, localization to specific 
compartments, and transcriptional regulation (Bertenshaw, Norcum, & Bond, 2003).  Meprins 
contain a signal peptide that directs the protein to the lumen of the endoplasmic reticulum (ER) 
during synthesis, and a propeptide that inhibits activity (Johnson & Bond, 1997).  The structure 
of meprins consists of two subunits, α and β (Johnson & Hersh, 1992).  The subunits are 42% 
identical at the amino acid level, highly glycosylated, and form disulfide-linked homo- or 
heterodimers (J. S. Bond & Beynon, 1995; Marchand, Tang, & Bond, 1994).  Each subunit has 
astacin-like catalytic domain with several protein-interaction domains (Tsukuba & Bond, 1998).  
Meprin A is a homooligomer of α-subunits or a heterooligomer of α/β subunits, while meprin B 
is a homooligomer of β-subunits (Johnson & Bond, 1998).   Although both forms of meprins 
prefer substrates containing at least 6 amino acids (Butler & Bond, 1988), meprin A selects 
amino acids that are small and hydrophobic within the P1´ site and prefers proline residues in P2´ 
site, while meprin B is predominantly an ASP/Glu-N peptidase with a preference towards acidic 
residues within the P1´site (Bertenshaw et al., 2001).  These differences can account for the 
diverse functions of the 2 meprin isoforms.   
          The research of Bertenshaw (2003) provided information on the structure of meprins.  
Meprin α-subunits associates into larger multimers while meprin B does not form mass 
complexes of higher levels.  Dimers of α/β only form tetramers.  The latent form of 
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homooligomer meprin A forms even larger complexes to the activated form.  The degree of 
multimerization has been deemed to be dependent upon the protein and salt concentration.   
 The location where meprin is found depends upon the subunit.  Meprins containing at 
least one β-subunit remain membrane-bound due to the transmembrane domain located near the 
carboxyl terminus of the β-subunit (J. S. Bond & Beynon, 1995).  Membrane-bound forms of 
kidney meprin have been found to be concentrated in the juxtamedullary region of cortex (Craig 
et al., 1987), and it was determined that meprin β-subunits in the mouse kidney are primary in 
the latent, proenzyme form (Butler & Bond, 1988).  Meprin A is secreted while mouse meprin B 
and heterooligomer A are membrane-bound.  Homooligomer A is able to be freed from the 
membrane due to a 56 amino acid inserted domain that permits the proteolytic event during 
maturation (Tang & Bond, 1998). 
2.3 Meprins and Ischemia-Reperfusion Induced Renal Injury 
  One of the functions of the kidney is to provide clearance of plasma polypeptides 
(Cuber, Bernard, Gibard, & Chayvialle, 1989).  Chronic renal failure patients have higher levels 
of peptides involved in gut mortality.  Meprins play a role in the catabolism of extracellular 
matrix (ECM) proteins.  The potential exist where the absence of meprins may account for some 
of the accumulation of ECM proteins that leads to fibrosis resulting in ESRD (Bertenshaw et al., 
2003).  Knowledge on the role(s) of meprins in ischemia-reperfusion induced injury is growing.  
Changes in the level of expression and localization of the meprin β-subunit have been associated 
with the pathology of ischemia-reperfusion-induced kidney injury in mice and rats (Bylander et 
al., 2008; Carmago et al., 2002; Trachtman et al., 1995; Walker et al., 1998).  It has been 
proposed that in IR-induced acute renal injury, depletion of oxygen and ATP results in 
accumulation of intracellular sodium, calcium, and reactive oxygen species.  These changes are 
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believed to activate various enzyme systems including proteases, resulting in disruption of the 
BBM cytoskeleton and membrane damage, subsequently leading to necrosis and apoptosis 
(Molitoris, Leiser, & Wagner, 1997).  Meprin is cytotoxic, and may play a role in IR injury 
(Carmago et al., 2002).  The latent homooligomer form of meprin A is not a toxic agent in IR 
(Bylander et al., 2008), suggesting that activation occurs in IR. 
            Studies with mouse models have increased our knowledge of the influence of meprins in 
IR-induced renal damage.  In 1995, Trachtman el al. showed that non-congenic mice strains with 
lower renal meprin levels developed less renal injury following IR.  In contrast, strains of mice 
with higher levels of the heterooligomer meprin A (α/β) had more severe IR damage when 
compared to strains that express meprin B only (Bylander et al., 2008).   In meprin B knockout 
mice there is less disruption and shedding in proximal tubule cell membranes, reduced 
inflammatory response, and an overall better preservation of kidney function after IR (Bylander 
et al., 2008).  In wild-type mice, kidney meprin B and homooligomeric meprin A are latent due 
to their prosequences that inhibit proteolytic activity (Butler & Bond, 1988; Villa, Bertenshaw, 
Bylander, & Bond, 2003).  The prosequence is removed, via an unknown mechanism, in 
membrane-bound meprin A.  Bylander et al., (2008) propose that the activated membrane-bound 
meprin A is the most likely damaging factor in vivo after IR. 
2.4 Osteosarcoma 9 
 Research has shown that meprins cause damage to the kidney subjected to ischemia-
reperfusion injury.  The identity of meprin substrates will help in understanding the mechanisms 
by which damage is occurring within the kidney.  Osteosarcoma 9 has been shown to interact 
with the C terminal tail of meprin β, and this interaction may provide a mechanism by which 
meprins modulate the hypoxia response.  OS9 plays a role in the Endoplasmic reticulum (ER)-
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associated degradation pathway.  Proteins that fail to fold or assemble with partnered subunits 
are selectively removed from the endoplasmic reticulum (ER) via ER-associated degradation 
pathway (ERAD).  Proteins selected for the ERAD pathway are polyubiquitinated and relocated 
into the cytosol for proteasome degradation (Romisch, 2005).  Studies have shown that 
osteosarcoma amplified 9, endoplasmic reticulum lectin (OS9) are upregulated in response to ER 
stress, and OS9 is associated with ERAD machinery and ERAD substrates (Alcock & Swanton, 
2009).  With the use of RNAi, OS9 was proven to be required for efficient ubquitination of 
glycosylated ERAD substrates.  OS9 aided in the transfer of misfolded proteins (Alcock & 
Swanton, 2009).   Osteosarcoma amplified 9, endoplasmic reticulum lectin is a protein coding 
gene (GenBank ID:  10956) located on 12q13 chromosome of humans that is overly expressed in 
osteosarcomas (Su, Hutter, Trent, & Meltzer, 1996).  OS9 is known to bind to HIF, and promote 
degradation of one of its subunits (Baek et al., 2005) .  The analysis of OS9’s cDNA sequence 
revealed 2785 bp with an open reading frame of 667 amino acids residues (Su et al., 1996).  Su et 
al. determined that the OS9 gene encoded a 2.8 kB mRNA transcribed in all of the tissue samples 
examined;  therefore, OS9 is ubiquitously expressed in human tissues. 
2.5 Interaction Between Meprin β and OS9  
 OS9 is a peripheral membrane protein associated with the cytoplasmic side of the ER, 
and OS9 may be involved in ER-Golgi transport of meprin B (Litovchick, Friedmann, & 
Shaltiel, 2002).  Meprin A undergoes proteolysis in the ER resulting in the removal of its short 
carboxyl-terminal cytoplasmic tail (Johnson & Hersh, 1992).  Litovchick et al. published work in 
2002 (Litovchick et al.) with the purpose of identifying proteins that interact with tail maintained 
by meprin B, and to deduce the role of the tail.  Litovchick earlier in 1998 found that the 
cytoplasmic domain of rat meprin B is indispensable for its ER-to-Golgi transport, and removal 
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results in entrapment of meprin B in ER (Litovchick, Chestukhin, & Shaltiel, 1998).  
Litovchick’s research in 2002 demonstrated that OS9 interacts specifically with the intracellular 
region of meprin B.  OS9 is a peripheral membrane protein associated with the cytoplasmic side 
of the ER, and OS9 may be involved in ER-Golgi transport of meprin B.   Non-spliced OS9 
binds to the tail of meprin B.  The 674Thr-Ala689 region of meprin B is critical for the binding of 
OS9 (Litovchick et al., 2002).  This same region is also required for ER-Golgi transport.  
Litovchick proposes that OS9 interaction with the tail may occur during maturation in ER.  In 
addition, immunofluorescence and fractionation showed that OS9 cell distribution is similar to 
some ER chaperones. 
 2.6 Hypoxia Response Genes 
 A cell survives and thrives under normoxic (normal oxygen) conditions.  When the levels 
of oxygen drop, then the cell is able to sense the difference in the oxygen level.  The cell can 
alter its energy metabolism using anaerobic glycolysis to produce ATP, but this is only a short-
term solution.  The cell must respond to this environmental stimulus in order to maintain 
regulation, and for long-termed survival.  Hypoxia induces genes to supply oxygen;  with 
hypoxia inducible factor 1 (HIF-1) controlling the expression of most of these genes (Semenza, 
1998).  A hypoxia inducible factor (HIF) is the cellular response to hypoxia.  HIF is the master 
regulator of hypoxia-response genes (Myllyharju & Schipani, 2010), and HIF-1 functions as a 
master regulator of oxygen homeostasis that mediates changes in gene transcription in response 
to changes in cellular oxygen levels (Baek et al., 2005).  An alternate means of ATP production 
is achieved by providing an oxygen-independent mechanism modulated by  HIF-1 (Baek et al., 
2005).  HIF-1 is required for transcriptional activation mediated by the erythropoietin gene 
enhancer in hypoxic cells (Semenza, 1994). Experimentation performed by Wang (1995) 
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evaluated the levels of protein and RNA in cells exposed to 1% oxygen for a predetermined time 
period before oxygen was replenished back to 20%.  The RNA and protein levels rapidly 
decayed which confirms HIF-1’s role as a mediator of transcriptional response to hypoxia.  The 
structure of HIF-1 consists of a heterodimer composed of 1 of 3 α-subunits (HIF-1α-2α-or-3α) 
and a β-subunit (Ema et al., 1997; Gu, Moran, Hogenesch, Wartman, & Bradfield, 1998; Tian, 
McKnight, & Russell, 1997; Wang & Semenza, 1995).  HIF-1β is constitutively located within 
the nucleus (Berchner-Pfannschmidt et al., 2004).  HIF-1 (alpha and beta) are basic-helix-loop-
helix-PAS proteins with expression being regulated by cellular oxygen tension (Wang, Jiang, 
Rue, & Semenza, 1995).  The proteolytic stability and transcriptional activity of HIF-1α -and 
HIF-2α is regulated by two separate oxygen-dependent  hydroxylation events (Myllyharju & 
Schipani, 2010).  Under normoxia, little to no HIFα is detectable in the nucleus.  HIFα contains 
an oxygen-depended degradation domain where two –Leu-X-X-Leu-Ala-Pro- sequences are 
hydroxylated during normal conditions by HIF prolyl 4-hdroxylase (HIF-P4H) (Bruick & 
McKnight, 2001; Epstein et al., 2001; Ivan et al., 2001).  The 4-hydroxyproline residues formed 
by the HIF-P4Hs are required for the binding to von Hippel-Lindau E3 ubiquitin complex 
(Myllyharju & Schipani, 2010).  This process is known as the ubiquitin proteasome pathway 
where HIF1α is constitutively synthesized, but destroyed when normoxic conditions exist 
(Berchner-Pfannschmidt et al., 2004; Kallio, Wilson, O'Brien, Makino, & Poellinger, 1999; 
Salceda & Caro, 1997).  HIFα is degraded by the 26S proteasome (Huang, Gu, Schau, & Bunn, 
1998).  The dependency of oxygen, during the binding of the von-Hippel-Lindau protein (pVHL) 
(Maxwell et al., 1999), depends on post-translational hydroxylation of HIF1α at proline residues 
564 and 402 by prolyl hydroxylases (Epstein et al., 2001; Ivan et al., 2001).  Oxygen is required 
for the activity carried out by prolyl hydroxylases. 
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 When hypoxic conditions arise, prolyl hydroxylation ceases,  HIFα is not recognized by 
the pVHL and therefore evades degradation (Berchner-Pfannschmidt et al., 2004). Consequently 
HIFα dimerizes with HIFβ , and is then translocated to the nucleus where it is bound to the HIF 
responsive elements (Myllyharju & Schipani, 2010).  Formed active complexes turn on 
expression of target genes including vascular endothelial growth factor (VEGF), erythropoietin, 
glucose transporter-1, and carbonic anhydrase (Bracken, Whitelaw, & Peet, 2003; Wenger, 
2002). 
 Beak et al. (2005) demonstrated the role of OS9 as a regulator of HIF1.  OS9 interacts 
with HIF1α to promote oxygen-dependent degradation of HIF-1α by the proteasome.  Beak’s 
research showed OS9 as a negative regulator of HIF1 that promotes prolyl hydroxylation by 
interacting with HIF-1α and PHDs.  A complex is formed with HIF1α, OS9, and PHD2 or 
PHD3.  OS9 PHD2 binds separately to HIF-1α at non-overlapping sites.  OS9 promotes the 
interaction of HIF-1α with PDH leading to hydroxylation followed by proteasomal degradation.  
While OS9 has been shown to interact with OS9, it’s not known if OS9 is a meprin substrate and 
how meprin cleavage of OS9 would impact the hypoxia response. 
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CHAPTER 3 
Materials and Methods 
3.1 Reagent Inventory  
 The following antibodies were purchased from Abcam, Cambridge, MA:  anti-GAPDH 
mouse monoclonal antibody, and anti-HIF1α rabbit polyclonal antibody.   Minimum essential 
medium eagle were purchased from the American type culture collection ATCC (Manassas, 
VA).  The following supplies were purchased from Bio-Rad Laboratories, Hercules, CA:  30% 
acrylamide (29:1 bis solution), anti-mouse IgG secondary antibody, anti-rabbit IgG secondary 
antibody, and Bio-Rad protein assay reagent.   A biotinylated protein ladder was purchased from 
Cell Signaling Technology (Danvers, MA).  Dr. Judith Bond of the Pennsylvania State 
University College of Medicine (Hershey, PA) donated anti-meprin-A rabbit polyclonal antibody 
(HMC14) and anti-meprin-B mouse polyclonal antibody (HMC77).  The following chemicals 
were purchased from Fisher Scientific (Pittsburgh, PA):  ammonium persulfate, dithiothreitol, 
ethylenediaminetetraacetic acid, protein markers , glycerol, glycine, hydrochloric acid, 
hydroxyethyl piperazineethanesulfonic acid, isobutyl alcohol, magnesium chloride, methanol, 
nonfat powdered milk, phosphate buffered saline, potassium chloride, sodium vanadate, Tris, 
Tris base, trypsin, tween 20, and β-mercaptoethanol.   Antibiotic-antimycotic and fetal bovine 
serum were purchased from Hyclone Laboratories (Logan, UT).  Dulbecco’s minimum essential 
medium was purchased from Life Technologies (Grand Island, NY).  Anti-OS9 rabbit polyclonal 
antibody and purified human OS9 protein were purchased from OriGene Technologies 
(Rockville, MD).  The following chemicals were purchased from Sigma-Aldrich, St. Louis, MO:  
actinonin, antimycin A, bromophenol blue, cobalt II chloride hexahydrate, sodium bicarbonate, 
sodium chloride, sodium dodecyl sulfate, tetramethylethylenediamine, tris (2-carboxyethyl) 
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phosphine hydrochloride, triton X-100, and 2-deoxy-D-glucose.  The following chemicals were 
purchased from Thermo Scientific, Waltham, MA:  ethyl alcohol 200 proof (Acros Organics), 
100X ethylenediaminetetraacetic acid solution, 100X halt protease inhibitor cocktail, and 
Supersignal West Pico Chemiluminescent substrate. 
3.2 Cell Culture   
 Human Embryonic Kidney 293 (HEK 293) cells were purchased from American Type 
Culture Collection (Manassas, Virginia) with the addition of meprin transfected cells gifted from 
the laboratory of Dr Judith Bond (Penn State College of Medicine, Hershey, PA).  Cells were 
propagated in minimum essential medium eagle supplemented with 10% FBS and antibiotics, 
subcultured, and preserved in liquid nitrogen.   The cell cultures were incubated at 37°C and 5% 
CO2 for the duration of the growth cycle.  The cell cultures were observed on the second day 
using an inverted microscope.   The cell cultures were observed daily to monitor the confluency 
of the cells.  The cell cultures were replaced with new complete growth media weekly.   The 
cells were grown to a confluency rate of at least 80% before being harvested.    
3.3 Oxygen Depletion 
 Oxygen depletion was induced in the HEK 293 cells using Cobalt (II) Chloride.  Cells 
were allowed to grow to 80% confluency in Eagle’s MEM medium with 10% FBS.  The media 
was changed to a serum-free medium containing 0.1% BSA overnight.  The cell cultures were 
exposed to 125 µM cobalt chloride (Sigma, St. Louis, MO) for pre-determined time intervals of 
0 min, 30 min, 1 hr, 2 hr, and 3 hr.   
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3.4 ATP Depletion   
 A combination of 2-deoxy-D-glucose and antimycin A was used to induce ATP depletion 
in the HEK 293 cells.  The cells were washed 2-3 times with warm, sterile-filtered PBS media.  
The cell culture medium was replaced with Dulbecco’s PBS “ATP-depletion medium” (Life 
Technologies, Grand Island, NY)  containing 1.5 mM CaCl2, 2 mM MgCl2, 2 mM deoxy-D-
glucose, and 10 µM antimycin A for 0 hr, 30 min, 1 hr, and 2 hr. 
3.5 Protein Extraction   
 A hypotonic buffer, a high salt buffer, and RIPA buffer were used for fractionation of 
proteins from the cultured cells.  The hypotonic buffer consisted of 10 mM Hepes (pH 7.9), 1.5 
mM MgCl2, 10 mM KCl, 0.5 mM DTT, 1 mM Na3VO4, and protease inhibitor/EDTA.  The high 
salt buffer was prepared by combining the following:  20 mM Hepes (pH 7.9), 420 mM NaCl, 
1.5 mM MgCl2, 0.5 mM DTT, 1 mM Na3VO4, 25% glycerol, and protease inhibitor/EDTA.  The 
RIPA buffer was prepared by combining 0.02 mM Hepes pH7.9, 0.015 mM NaCl, 0.1 mM 
Triton-X 100, 0.01 mM SDS, 1 mM Na3VO4, and protease inhibitor cocktail/EDTA.  Cells were 
rinsed with ice cold PBS twice.  The last wash was aspirated completely.  Three-hundred µl of 
hypotonic buffer was added to each 100 mm dish.  The dishes were allowed to sit on ice for 30 
minutes, and swirled every 10 minutes.  The cells were harvested using a cell scrapper.  The 
lysate was transferred to a microfuge tube, and centrifuged at 4° C for 10 minutes at a speed of 
15,000 x g.  The supernatant was transferred to a new tube, and labeled as the cytoplasmic 
extract.  Fifty µl of high salt buffer was added to the pellet, and the pellet was resuspended in the 
solution.  This was placed on ice for 20 minutes, and centrifuged once again 4° C for 10 minutes 
at a speed of 15,000 x g.   The supernatant was transferred to a new tube and labeled as the 
nuclear-enriched extract.  The pellet was resuspended in 100 µl of RIPA buffer, and allowed to 
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sit on ice for 20 minutes.  The microfuge tube was centrifuged 4° C for 10 minutes at a speed of 
15,000 x g.  The supernatant was transferred to a new tube labeled as membrane-enriched 
fraction.   All fractions were kept on ice if protein quantification was to be immediately 
performed, or frozen at -20° C until a later date when the protein quantification was to be 
performed. 
3.6 Determination of Protein Concentration   
 The concentrations of proteins obtained from the protein extraction were determined 
using Bio-Rad’s protein assay reagent (Hercules, CA).   This assay is based upon the Bradford 
method.  The prepared samples were allowed to sit at room temperature for 10 minutes before 
having their optical densities read on VIS light at 595.  Microsoft spreadsheet was utilized in 
order to plot the standard curve.  The estimated protein concentrations were derived from the 
standard curve. 
3.7 Electrophoretic Separation of Proteins by SDS-PAGE 
 Proteins were separated by electrophoresis on 10% polyacrylamide gels. Equal amounts 
of proteins ranging from 40-60 µg were loaded in each well.  Five µl EZ-Run Pre-Stained Rec 
Protein LadderTM (Fisher Scientific, Pittsburgh, PA) was loaded into the first well and used for 
tracking protein migration.   The amounts required of each were obtained from using a pre-
formed excel template.  The samples were boiled in SDS sample buffer with β mercaptoethanol 
for 5 minutes before loading.  The gels were run at 200 V for roughly 45 min or until the 
migration front had reached the bottom of the gel. 
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3.8 Western Blot Analysis   
 The polyacrylamide gel containing the separated proteins was positioned on 
nitrocellulose membrane that was presoaked in transfer buffer (250 nM Tris, 192 nM Glycine, 
and 20% Methanol), and embedded between two thick, pieces of soaked filter paper.  The unit 
was fully assembled, and allowed to transfer at 15 V for one hour. The membrane was incubated 
in 8% milk in Tris-buffered saline with 0.1% Tween-20 (TBS-T) for one hour at room 
temperature to block non-specific binding sites.  The membrane was incubated in primary 
antibody with gentle agitation at room temperature for one hour, or overnight at 4° C.  The 
membrane was then washed with TBS-T three times for 10 minutes per cycle at room 
temperature on a shaker.  The secondary antibody was added using the same procedure with the 
exception that the secondary antibody is added in TBS-T in lieu of milk.  The membrane 
underwent its final wash with TBS-T with three cycles at 15 minutes each. 
 The Western blots were developed using Chemiluminescent Substrates (Thermo 
Scientific, Waltham, MA).  The film was processed using the X-ray developer.  The quantitation 
of the protein bands was performed using Bio-Rad’s GS-800 calibrated densitometer along with 
QuantityOne software. 
3.9 Confirmation of Meprin B Expression by Meprin β cDNA Transfected Cells  
 In order to assess the interaction of meprin with OS9, and HIF1α, it was necessary to 
verify the presence of meprins within the transfected cells.  Using Western blot analysis, meprin 
B was detected in the cytosolic and membrane-enriched fraction (Figure 1).  Furthermore, the 
detection of meprin within the cytosolic fraction provides evidence that OS9 and meprin can be 
found within close proximity to one another within the cell. 
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3.10 Determination of OS9 Cellular Localization   
 Western blot analysis were performed on all three cell genotypes HEK 293 cells to 
determine the cellular localization for OS9.   OS9 was strongly detected in the nuclear fraction 
for all of the cell proteins.  Faint bands were also detected within the cytosolic fraction.  This 
information provided the basis for only using the nuclear fraction for carrying out the Western 
immunoblots when investigating OS9. 
3.11 Determining If Meprins Degrade OS9 
 To determine if meprins are capable of cleaving OS9, purified activated forms of meprin 
A and meprin B (4 nM) were co-incubated with purified OS9 (92 nM) in buffer consisting of 20 
mM Tris and 150 mM NaCl, pH 7.5.   Control reactions were incubated in buffer without 
meprins.  Equal volumes of proteins were taken from the reaction mixture at 0, 0.5, 1, 2, 3, and 4 
hours.  The reaction was stopped by addition of SDS buffer and boiling for 5 minutes.  The 
samples were loaded onto 10% polyacrylamide gels and separated by electrophoresis as 
described above, followed by Western blot analysis with anti-OS9 antibodies.   
3.12 Determining Whether Degradation of OS9 Is Meprin Isoform-Specific  
 To confirm that degradation of OS9 was meprin-specific, purified OS9 was co-incubated 
with activated meprin B as described above.  Controls reactions were included with the 
following; (1) activated meprins that were pre-incubated with known meprin inhibitors (EDTA 
and actinonin) for 1 hour, (2) latent forms of meprin B, and (3) trypsin-treated buffer.  The 
reactions were incubated at 37oC for 1 hour and the proteins separated by electrophoresis and 
detected by Western blot analysis. 
  
 4.1 Cellular Localization of Meprin B and OS9
 Western blot analysis showed that mepr
enriched and cytosolic-enriched protein fractions from
This data confirmed that the cells are expressing meprin
cytosolic fraction places meprin in 
Figure 1. Evaluation of meprin B expression in meprin 
 
 OS9 proteins were most abundant in the nuclear
cell genotypes (non-transfected, meprin 
cells.  Western blot analysis revealed traced amounts of OS9 within the cytosolic fraction of the 
non-transfected cells as seen in Figure
most amount of OS9 from all cell genotypes provided the basis for only using the nuclear 
fraction for the protein samples used in all 
 
CHAPTER 4 
 Results    
  
in B proteins were present in the membrane
 the meprin β transfected cells (Figure 1).  
.  The confirmation of meprin within the 
close proximity to OS9. 
β transfected MDCK cells
-enriched protein fraction
alpha-transfected, and meprin beta-transfected
 2.  Determining that the nuclear fraction contained the 
subsequent Western blots. 
21 
-
 
.   
 from all three 
) HEK293 
 Figure 2. Cellular localization of 
 
4.2 Increase of OS9 in Oxygen-
 With the location of OS9 being established within the cell fraction and the cells 
evaluation for the expression of meprin, all genotypes of HEK 293 cells were treated for oxygen
depletion with the purpose of evaluating the presence of OS9 within the nuclear fraction.  OS9 
was observed at all time intervals for all of the HEK 293 genotypes.  Evaluating the data from 
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Figure 3.  Increase of OS9 in oxygen
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4.6 Meprin B Degradation of OS9 
 In order to determine if meprin cleaves OS9, homomeric active forms of meprin A and B 
were incubated with purified recombinant human OS9 for O hr, 0.25 hr, 0.5 hr, 1 hr, 2 hr, and 4 
hours.  A buffer containing no meprin 
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4.7 Meprin B Degradation of OS9 
 The specificity of meprin cleaving OS9 was evaluated by incubating purified 
recombinant human OS9 with activated meprins, latent forms of meprins, buffer containing no 
meprin, and buffers containing meprin inhibitor
Western blot for OS9 was performed.  Intense bands for OS9 were detected in the samples 
containing OS9 with meprin-free buffer, OS9 with the latent form of meprin, and OS9 with the 
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 inhibitor of EDTA.  Extremely faint bands were detected in the samples containing OS9 with the 
activated form of meprin A, and OS9 with the inhibitor actinonin.  The data supports that the 
activated forms of meprin degrades OS9 resulting in the observation of no bands, and 
demonstrating that meprin B degradation of OS9 is meprin specific 
 
Figure 7.  Meprin B degradation of OS9 is meprin specific.
  
(Figure 7). 
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CHAPTER 5 
 
Discussion and Conclusion 
 Ischemia-reperfusion injury is the leading cause of acute kidney disease (Gunaratnam & 
Bonventre, 2009).  On average, 2.5% of hospitalized patients will die from complications 
resulting from ischemic acute tubular necrosis (Ympa et al., 2005).  It is necessary to determine 
what is causing the damage inside the organ when normal blood flow is restored after a period of 
ischemia and hypoxia.   Meprins constitute 5% of the total amount of proteins found in the 
kidneys’ brush-border membrane, and meprins have been associated in the pathology of 
ischemia-reperfusion induced kidney failure. It has been shown in mice that lower levels of 
meprin and no meprin (knockout) lead to less renal injury after ischemia/reperfusion.  This 
research provided another link in the mechanism for how meprins enhance damage to ischemia-
reperfusion injured kidney. 
  An interaction between OS9 and meprin B has previously been described by Litovchick 
et al. (2002) suggesting that OS9 may be involved in ER to Golgi transport of meprin B.  A gap 
was created when OS9 has never been identified as a meprin substrate.  The goal of this study 
was to determine if OS9 is a meprin substrate.  The identity of a meprin substrate will provide to 
a better understanding of how meprins are enhancing damage to the kidneys after an episode of 
ischemia-reperfusion injury;  thus, yielding to developments in the prevention and treatment of 
kidney damage resulting from ischemia-reperfusion injury. 
 To test if OS9 is a meprin substrate, purified human OS9 was co-incubated with meprin 
A, meprin B, or no meprin.  Results revealed that only meprin B degrades OS9.  When the 
experiment was repeated using less sample, no OS9 was observed at any time points after 0 hour.  
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This suggests that not only is OS9 being degraded by meprin B, but it is also fast acting.  An 
enzyme has more potential to create damage when the rate of reaction is rapid. 
 The degradation of OS9 by meprin was further investigated using various experimental 
variables to determine the specificity of meprin degradation of OS9.  OS9 was incubated with 
activated and latent isoforms of meprin, and with known meprin inhibitors.  It was determined 
that the degradation of OS9 is specific to activated meprin B.  This research is the first to identify 
OS9 as a meprin substrate, and that degradation only occurs by meprin B.     
 Meprins relocalize from the brush-border membrane to the cytosol after ischemia-
reperfusion.  It was confirmed by Western blot that meprin is found within the cytosolic fraction.  
Meprin being found within the cytosol puts the meprin in close proximity to OS9 located on the 
cytoplasmic side of the ER.  If meprin was not found within the cytosol, the potential would not 
exist for OS9 and meprin to interact with one another. 
  OS9 is associated with the ER-associated degradation (ERAD) pathway 
machinery and ERAD substrates.  Misfolded proteins are recognized by the ERAD pathway, and 
retranslocated back across the ER membrane in order to be degraded by the cytosolic 
proteasome.  OS9 binds to the misfolded polypeptide within the lumen of the ER before 
transferring the protein to the HRD1 ubiquitin ligase complex transfer and polyubiquitination.  
OS9 degradation by meprin B would inhibit the ERAD pathway from occurring.  With the 
ERAD unable to eliminate misfolded proteins, the proteins would begin to build up within the 
cell.  The accumulation of protein within the fragile cell could lead to additional damage.  Higher 
levels of peptides are observed in patients with chronic renal failure when their kidneys are 
unable to provide clearance.  Data from the current study suggests that the mechanism of damage 
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resulting to the kidney upon ischemia-reperfusion is in part the result of the trafficking of 
proteins being halted when meprin B degrades OS9. 
 The second objective of this study was to determine whether OS9 interacts with meprins 
and HIF1α under hypoxic conditions.  To date, there is no known correlation existing between 
OS9 and HIF1α.  Hypoxia occurs as a result of ischemia.  A cell responds to the low oxygen 
level via inducing hypoxia inducible factors with HIF1 functioning as the master regulator of 
oxygen homeostasis.  Beak et al. (2005) demonstrated that OS9 interacts with HIF1α and HIF1α 
prolyl hydroxylases acting as a negative regulator of HIF1 in oxygen homeostasis. Using RNAi, 
Beak et al. discovered OS9’s gain-of-function to include HIF1α hydroxylation, HIF1α 
proteasomal degradation, and HIF1-mediated degradation.  OS9 loss-of-function included 
increase levels of HIF1α, and HIF1-mediated transcription.  Taking this into consideration, an 
increased amount of HIF1α would be expected in cells depleted of oxygen and exposed to 
meprins.  The results obtained from this study found that HIF1α stabilizes in a time-dependent 
course when cells are depleted of oxygen.  This is the first time that HIF1α is evaluated in cells 
transfected with meprin.  An increase in HIF1α was observed in the alpha transfected cells 
compared to the non-transfected cells.  The biggest increase in the amount of HIF1α was 
detected among the beta transfected cells.  This would be expected if OS9 is being degraded by 
meprin B.  The degraded OS9 is no longer able to interact with HIF1α and HIF1α prolyl 
hydroxylases to promote degradation of HIF1α.  The extra accumulation of HIF1α protein could 
potentially result in additional damage to the cell. 
 In conclusion, this research established that OS9 is a meprin B substrate.   Meprin A did 
not cleave or degrade OS9 suggesting isoform-specific substrate preference.  HIF1α was shown 
to be affected by the degradation of OS9 by meprin B;  thus, impacting the hypoxia response of 
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the cell.  It was proposed that cell damage observed in ischemia-reperfusion injury may be 
partially the result of the ERAD pathway being modulated when OS9 is degraded by meprin B.   
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CHAPTER 6 
Future Research 
 The next step to be performed to continue working on this project is concluding the ATP-
depletion experiments in the HEK293 cells.  Preliminary data using MDCK cells were obtained, 
but due to time restraints, ATP-depletion portion of this project is not complete.  The protocol 
had to be modified due to cells being lost upon extraction.  The new protocol for extracting cells 
has been proven to be successful, and is ready to be carried out.  Three Western blots each for 
OS9 and HIF1α will provide statistically sound data that will be ready to publish.  Also, the data 
obtained from in vitro results can be combined and compared to in vivo results from the mice 
studies. 
 Immunohistochemistry for OS9 and HIF1α in the HEK293 cells depleted of oxygen and 
ATP would be the last component of this project.  The visualization would provide direct 
evidence to what is occurring to OS9 and HIF1α within the cell.  Additionally, a commercially 
available ERAD pathway inhibitor could be purchased to compare non-transfected cells to 
meprin β transfected cells.  The meprin B degradation resulting in the stop of protein trafficking 
in the ERAD pathway should result in the same findings where compared to an ERAD pathway 
inhibitor in the non-transfected cells.  Immunohistochemistry would serve purposely for ERAD 
pathway as well. 
 In the near future, a large scale search for additional meprin substrates can be performed 
using techniques such as microarrays and mass spectrometry.  The ultimate goal is to not treat 
kidney disease, but to prevent damage and disease.  The identification of meprin substrates will 
aide in drug development.  Meprin inhibitors such as actinonin are now available, but they are 
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not meprin specific.  The identification of all meprin substrates would lead to better drugs that 
could be used in personalized medicine. 
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